新生儿持续性肺动脉高压的肺血管扩张剂治疗
Pulmonary vasodilator therapy in persistent pulmonary hypertension of the newborn.
作者信息
Kulik T J, Lock J E
出版信息
Clin Perinatol. 1984 Oct;11(3):693-701.
Abstract
A review of the physiology of persistent pulmonary hypertension of the newborn is provided, followed by a critical review of many of the agents that have been employed to treat this condition. In addition, the authors speculate on what type of pharmacologic therapy may prove useful in the future.
摘要
本文首先回顾了新生儿持续性肺动脉高压的生理学，随后对众多用于治疗该病症的药物进行了批判性综述。此外，作者还推测了未来可能证明有用的药物治疗类型。
相似文献
1
Pulmonary vasodilator therapy in persistent pulmonary hypertension of the newborn.新生儿持续性肺动脉高压的肺血管扩张剂治疗
Clin Perinatol. 1984 Oct;11(3):693-701.
2
Neonatal 'pulmonary vasodilator' drugs. Current status.
Dev Pharmacol Ther. 1984;7(1):1-20.
3
Perinatal vascular development.围产期血管发育
Cardiovasc Res. 2001 Jul;51(1):7-8. doi: 10.1016/s0008-6363(01)00334-0.
4
Persistent pulmonary hypertension of the newborn: experience in a single institution.新生儿持续性肺动脉高压：单机构经验
Acta Paediatr Taiwan. 2001 Mar-Apr;42(2):94-100.
5
Vasodilators in persistent pulmonary hypertension of the newborn: a need for optimal appraisal of efficacy.新生儿持续性肺动脉高压中的血管扩张剂：需要对疗效进行最佳评估。
Dev Pharmacol Ther. 1992;19(2-3):62-8. doi: 10.1159/000457466.
6
Tolazoline therapy in newborns with persistent pulmonary hypertension.妥拉唑啉治疗新生儿持续性肺动脉高压
Taiwan Yi Xue Hui Za Zhi. 1984 Mar;83(3):299-306.
7
8
Primary pulmonary hypertension.
Annu Rev Med. 1980;31:421-31. doi: 10.1146/annurev.me.31.020180.002225.
9
Cerebral blood flow during treatment for pulmonary hypertension.肺动脉高压治疗期间的脑血流量。
Arch Dis Child Fetal Neonatal Ed. 1999 Jan;80(1):F30-3. doi: 10.1136/fn.80.1.f30.
10
The pharmacologic treatment of newborn diaphragmatic hernia--a 2-year evaluation.新生儿膈疝的药物治疗——一项为期两年的评估。
J Pediatr Surg. 1980 Aug;15(4):384-94. doi: 10.1016/s0022-3468(80)80741-x.
引用本文的文献
1
Persistent Pulmonary Hypertension of Newborns Secondary to Labile Hypoxemia Associated With Cyanosis: A Case Series.继发于与发绀相关的不稳定低氧血症的新生儿持续性肺动脉高压：病例系列
Cureus. 2024 Feb 11;16(2):e54016. doi: 10.7759/cureus.54016. eCollection 2024 Feb.
2
Molecular physiopathogenetic mechanisms and development of new potential therapeutic strategies in persistent pulmonary hypertension of the newborn.新生儿持续性肺动脉高压的分子生理病理机制及新潜在治疗策略的发展
Ital J Pediatr. 2015 Feb 8;41:6. doi: 10.1186/s13052-015-0111-0.
3
Effects of magnesium sulphate and nitric oxide in pulmonary hypertension induced by hypoxia in newborn piglets.硫酸镁和一氧化氮对新生仔猪缺氧诱导的肺动脉高压的影响。
Arch Dis Child Fetal Neonatal Ed. 1994 Nov;71(3):F151-5. doi: 10.1136/fn.71.3.f151.
4
Effect of blood pressure cuffs on neonatal circulation: their potential application to newborns with persistent pulmonary hypertension.血压袖带对新生儿循环的影响：其在持续性肺动脉高压新生儿中的潜在应用。
Pediatr Cardiol. 1995 Jan-Feb;16(1):20-3. doi: 10.1007/BF02310329.
5
Persistent pulmonary arterial hypertension of the newborn.新生儿持续性肺动脉高压
Indian J Pediatr. 1992 Nov-Dec;59(6):735-9. doi: 10.1007/BF02859410.
本文引用的文献
1
Efficacy and Safety of IV Sildenafil in the Treatment of Newborn Infants with, or at Risk of, Persistent Pulmonary Hypertension of the Newborn (PPHN): A Multicenter, Randomized, Placebo-Controlled Trial.静脉注射西地那非治疗新生儿持续性肺动脉高压（PPHN）或有PPHN风险的疗效和安全性：一项多中心、随机、安慰剂对照试验
J Pediatr. 2021 Oct;237:154-161.e3. doi: 10.1016/j.jpeds.2021.05.051. Epub 2021 May 27.
2
Transitioning From Intravenous to Subcutaneous Prostacyclin Therapy in Neonates With Severe Pulmonary Hypertension.重度肺动脉高压新生儿从静脉注射前列环素治疗转换为皮下注射前列环素治疗
J Pediatr Pharmacol Ther. 2020;25(7):647-653. doi: 10.5863/1551-6776-25.7.647.
3
Efficacy of Milrinone Plus Sildenafil in the Treatment of Neonates with Persistent Pulmonary Hypertension in Resource-Limited Settings: Results of a Randomized, Double-Blind Trial.米力农联合西地那非治疗资源有限地区持续性肺动脉高压新生儿的疗效：一项随机、双盲试验的结果。
Paediatr Drugs. 2020 Dec;22(6):685-693. doi: 10.1007/s40272-020-00412-4.
4
Targeted Therapy for Pulmonary Hypertension in Premature Infants.早产儿肺动脉高压的靶向治疗
Children (Basel). 2020 Aug 15;7(8):97. doi: 10.3390/children7080097.
5
Early use of combined exogenous surfactant and inhaled nitric oxide reduces treatment failure in persistent pulmonary hypertension of the newborn: a randomized controlled trial.早期使用联合外源性表面活性剂和吸入一氧化氮可降低新生儿持续性肺动脉高压的治疗失败率：一项随机对照试验。
J Perinatol. 2021 Jan;41(1):32-38. doi: 10.1038/s41372-020-00777-x. Epub 2020 Aug 13.
6
Pulmonary hypertension in bronchopulmonary dysplasia.支气管肺发育不良相关肺动脉高压。
Pediatr Res. 2021 Feb;89(3):446-455. doi: 10.1038/s41390-020-0993-4. Epub 2020 Jun 10.
7
AMP-Kinase Dysfunction Alters Notch Ligands to Impair Angiogenesis in Neonatal Pulmonary Hypertension.AMP 激酶功能障碍改变 Notch 配体，损害新生儿肺动脉高压中的血管生成。
Am J Respir Cell Mol Biol. 2020 Jun;62(6):719-731. doi: 10.1165/rcmb.2019-0275OC.
8
Inhaled Nitric Oxide Is Associated with Improved Oxygenation in a Subpopulation of Infants with Congenital Diaphragmatic Hernia and Pulmonary Hypertension.吸入一氧化氮可改善先天性膈疝和肺动脉高压患儿亚群的氧合。
J Pediatr. 2020 Apr;219:167-172. doi: 10.1016/j.jpeds.2019.09.052. Epub 2019 Nov 6.
9
EXPRESS: Sildenafil for bronchopulmonary dysplasia and pulmonary hypertension: a meta-analysis.快报：西地那非用于支气管肺发育不良和肺动脉高压：一项荟萃分析。
Pulm Circ. 2019 Feb 26;9(3):2045894019837875. doi: 10.1177/2045894019837875.
10
Inhaled Epoprostenol for Pulmonary Hypertension Treatment in Neonates: A 12-Year Experience.吸入性前列环素治疗新生儿肺动脉高压：12 年经验。
Am J Perinatol. 2019 Sep;36(11):1142-1149. doi: 10.1055/s-0038-1676483. Epub 2018 Dec 14.
Zotero 插件